Global Health Limited management will engage with institutional investors during meetings scheduled in Singapore on June 09 and June 10, 2026. The interaction is part of the Kotak Institutional Equity India Corporate Day - Singapore 2026. The company confirmed that no unpublished price sensitive information will be shared during the event.

The disclosure was made to the stock exchanges pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meetings will be conducted in person, featuring both one-to-one and group discussions with investors.

Rahul Ranjan, Company Secretary & Compliance Officer, signed the intimation on behalf of Global Health Limited. The company noted that the schedule is subject to change in case of unforeseen circumstances involving analysts, investors, or the company.

Global Health Ltd. recorded a notable block trade on the National Stock Exchange (NSE), with approximately 150,070 shares transacted at a price of ₹1207.20 per share, aggregating to a total deal value of ₹18.12 crores.

Block Trade Details

The following table summarises the key parameters of the block trade:

Block trades are large, privately negotiated securities transactions that are executed outside of the open market to minimise the price impact typically associated with significant buy or sell orders. Such transactions are generally associated with institutional investors, including mutual funds, foreign portfolio investors, or other large financial entities.

Market Significance

The execution of a block trade of this scale on the NSE underscores substantial institutional interest in Global Health Ltd. at the prevailing price level of ₹1207.20 per share. The transaction involving approximately 150,070 shares at a cumulative value of ₹18.12 crores reflects a sizeable movement of the company's equity in a single deal.